Xiang et al.144 delivered LMP2-mRNA LNPs to tumor-draining lymph nodes (TDLN) for the purpose of inducing activation and cytotoxicity of CD8+ T cells against tumor cells expressing LMP2. Here, PSMB9 is linked to neoplasm.